Levothyroxine Gel Capsules and Tinnitus
Levothyroxine gel capsules themselves do not directly cause tinnitus in patients with normal thyroid function tests. The medication's active ingredient (levothyroxine) is identical across all formulations—tablets, gel capsules, or liquid preparations—and tinnitus is not listed as a direct adverse effect of levothyroxine in FDA labeling 1.
Understanding the Relationship
The FDA-approved adverse reactions for levothyroxine products include cardiovascular, neurological, gastrointestinal, and dermatologic effects, but tinnitus is notably absent from this list 1. The documented adverse reactions include:
- Central nervous system: headache, hyperactivity, nervousness, anxiety, irritability, insomnia
- Cardiovascular: palpitations, tachycardia, arrhythmias
- Other systems: tremors, muscle weakness, hair loss, menstrual irregularities
However, tinnitus is not among these recognized effects.
The Actual Culprit: Thyroid Dysfunction Itself
One observational study found a statistical association between levothyroxine intake and tinnitus 2, but this is critically important to interpret correctly: the association likely reflects the underlying thyroid dysfunction requiring treatment, not the medication itself. Patients with dysthyroidism (both hypo- and hyperthyroidism) showed correlation with tinnitus in this study, suggesting the thyroid disorder—not its treatment—is the relevant factor.
Key Clinical Considerations
If Your Patient Has Normal Thyroid Function Tests:
- TSH, free T4, and T3 are all within normal range: The levothyroxine formulation (gel capsule vs. tablet) is not causing tinnitus
- Look elsewhere for the cause: Evaluate for other common tinnitus etiologies (noise exposure, ototoxic medications, cardiovascular disease, TMJ disorders, anxiety/depression) 2, 3
If Switching Formulations Coincided with Symptom Onset:
Consider these possibilities instead:
Hypersensitivity to inactive ingredients: Gel capsules contain different excipients than tablets. Hypersensitivity reactions to inactive ingredients can occur and may include various symptoms, though tinnitus specifically is not commonly reported 1
Absorption differences leading to overtreatment: Gel capsules and liquid formulations may have enhanced bioavailability compared to tablets 4. If the patient is now slightly over-replaced (even with "normal" labs), subtle hyperthyroidism could theoretically contribute to symptoms. Recheck TSH within 4-8 weeks of any formulation change 5
Coincidental timing: The tinnitus may have developed independently around the time of the switch
Common Pitfall to Avoid
Do not assume formulation equivalence without verification. When switching between levothyroxine formulations (tablet to gel capsule, or vice versa), guidelines recommend rechecking TSH within 4-8 weeks 5. Different formulations may have different absorption characteristics, particularly gel capsules and liquid preparations which can have enhanced bioavailability 4.
Bottom Line for Your Patient
Since thyroid function tests are normal, the gel capsule formulation is not the cause of tinnitus. The levothyroxine molecule itself does not cause tinnitus as a pharmacologic effect. Pursue standard tinnitus evaluation focusing on audiologic assessment, cardiovascular risk factors, medication review for ototoxic agents, and screening for anxiety/depression—all of which showed associations with tinnitus in clinical studies 2, 3.